Evaluation of the effects of different sampling schedules on the assessment of bioequivalence
- At: 2008 FIP Congress in Basel (Switzerland)
- Type: Poster
- By: PORTA, Valentina (College of Pharmaceutical Sciences, University of São Paulo, SÃo Paulo, Brazil)
- Co-author(s): Kano, Eunice Kazue (College of Pharmaceutical Sciences, University of São Paulo, SÃO PAULO, Brazil)
Fukuda, Kazuo (College of Pharmaceutical Sciences, University of São Paulo, SÃO PAULO, Brazil)
Chiann, Chang (Institute of Mathematics and Statistics, University of São Paulo, Brazil)
Bioequivalence studies are designed to compare the in vivo performance of different pharmaceutical products. The most frequently used pharmacokinetic parameters to evaluate bioequivalence are area under the plasma concentration-time curve (AUC), maximum plasmatic concentration (Cmax) and time to achieve Cmax (Tmax). Accuracy in measuring.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.